News

Cancer doctors pledge to widen access to pain relief in developing countries

BMJ 2010; 341 doi: 10.1136/bmj.c4645 (Published 26 August 2010)
Cite this as: BMJ 2010;341:c4645

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Tatum Anderson
  1. 1London

    Cancer advocates plan to broker deals with drug companies to get cheaper, more plentiful supplies of pain relief drugs to patients in developing countries using models pioneered in the field of HIV/AIDS.

    The plans form part of the Global Access to Pain Relief Initiative (GAPRI), a strategy launched at the World Cancer Congress, in China on 19 August. Led by the International Union Against Cancer (UICC), which represents 350 cancer charities including Cancer Research UK, GAPRI has the backing of organisations including the World Health Organization, the American Cancer Society, and the World Economic Forum.

    GAPRI will tackle the lack of access to strong opioid based pain relief. Today, a few rich nations, including the UK and US, consume …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular